Eikelboom JW - Search Results

1

Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.

Kaplovitch E, Eikelboom JW, Dyal L, Aboyans V, Abola MT, Verhamme P, Avezum A, Fox KAA, Berkowitz SD, Bangdiwala SI, Yusuf S, Anand SS. Kaplovitch E, et al. Among authors: eikelboom jw. JAMA Cardiol. 2021 Jan 1;6(1):21-29. doi: 10.1001/jamacardio.2020.4390. JAMA Cardiol. 2021. PMID: 32997098 Free PMC article. Clinical Trial.

2

Low rates of preventive practices in patients with peripheral vascular disease.

Anand SS, Kundi A, Eikelboom J, Yusuf S. Anand SS, et al. Can J Cardiol. 1999 Nov;15(11):1259-63. Can J Cardiol. 1999. PMID: 10579741

3

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.

Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Eikelboom JW, et al. Circulation. 2002 Apr 9;105(14):1650-5. doi: 10.1161/01.cir.0000013777.21160.07. Circulation. 2002. PMID: 11940542

4

Antiplatelet agents in acute coronary syndromes.

Eikelboom JW, Anand S. Eikelboom JW, et al. Semin Vasc Med. 2003 Nov;3(4):403-14. doi: 10.1055/s-2004-817689. Semin Vasc Med. 2003. PMID: 15199447 Review.

5

Congestive heart failure complicating non-ST segment elevation acute coronary syndrome: incidence, predictors, and clinical outcomes.

Mehta SR, Eikelboom JW, Demers C, Maggioni AP, Commerford PJ, Yusuf S. Mehta SR, et al. Among authors: eikelboom jw. Can J Physiol Pharmacol. 2005 Jan;83(1):98-103. doi: 10.1139/y05-003. Can J Physiol Pharmacol. 2005. PMID: 15759056 Clinical Trial.

6

Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.

Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S. Eikelboom JW, et al. Circulation. 2005 Dec 20;112(25):3855-67. doi: 10.1161/CIRCULATIONAHA.105.573550. Epub 2005 Dec 12. Circulation. 2005. PMID: 16344381

7

Management of antiphospholipid antibody syndrome: a systematic review.

Lim W, Crowther MA, Eikelboom JW. Lim W, et al. Among authors: eikelboom jw. JAMA. 2006 Mar 1;295(9):1050-7. doi: 10.1001/jama.295.9.1050. JAMA. 2006. PMID: 16507806 Review.

8

Adverse impact of bleeding on prognosis in patients with acute coronary syndromes.

Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Eikelboom JW, et al. Circulation. 2006 Aug 22;114(8):774-82. doi: 10.1161/CIRCULATIONAHA.106.612812. Epub 2006 Aug 14. Circulation. 2006. PMID: 16908769

9

Aspirin resistance.

Tran HA, Anand SS, Hankey GJ, Eikelboom JW. Tran HA, et al. Among authors: eikelboom jw. Thromb Res. 2007;120(3):337-46. doi: 10.1016/j.thromres.2006.08.014. Epub 2007 Jan 22. Thromb Res. 2007. PMID: 17241655 Review.

10

Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.

Mehta SR, Granger CB, Eikelboom JW, Bassand JP, Wallentin L, Faxon DP, Peters RJ, Budaj A, Afzal R, Chrolavicius S, Fox KA, Yusuf S. Mehta SR, et al. Among authors: eikelboom jw. J Am Coll Cardiol. 2007 Oct 30;50(18):1742-51. doi: 10.1016/j.jacc.2007.07.042. Epub 2007 Oct 15. J Am Coll Cardiol. 2007. PMID: 17964037 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

590 results

Search Page